MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PTGX has $697,459K in assets. $41,986K in debts. $193,712K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1775.61%
Quick Ratio
1775.61%
Cash Ratio
560.69%
Debt to Asset Ratio
6.02%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Marketable securities - noncurre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other payab...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Contract asset
---23,363
Cash and cash equivalents
193,712 128,390 113,713 168,543
Marketable securities
354,074 438,974 462,404 401,922
Receivable from collaboration partner
53,663 121 583 -
Prepaid expenses and other current assets
12,006 10,089 9,724 8,698
Total current assets
613,455 577,574 586,424 602,526
Marketable securities - noncurrent
72,548 78,638 102,703 102,493
Property and equipment, net
3,778 3,860 4,100 4,108
Restricted cash - noncurrent
288 287 287 290
Operating lease right-of-use asset
7,390 7,829 8,174 8,589
Total assets
697,459 668,188 701,688 718,006
Accounts payable
8,437 5,339 5,646 3,249
Accrued expenses and other payables
17,491 28,269 22,868 15,397
Deferred revenue
6,282 9,550 14,200 14,688
Operating lease liability
2,339 2,283 2,228 2,173
Total current liabilities
34,549 45,441 44,942 35,507
Deferred revenue - noncurrent
--2,788 5,375
Operating lease liability - noncurrent
7,437 8,040 8,521 9,106
Total liabilities
41,986 53,481 56,251 49,988
Common stock, 0.00001 par value, 180,000,000 shares authorized 64,227,057 and 62,577,897 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
1 1 1 1
Additional paid-in capital
1,122,629 1,084,736 1,071,198 1,054,980
Accumulated other comprehensive (loss) income
-269 641 525 -15
Accumulated deficit
-466,888 -470,671 -426,287 -386,948
Total stockholders' equity
655,473 614,707 645,437 668,018
Total liabilities and stockholders' equity
697,459 668,188 701,688 718,006
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$354,074K Cash and cashequivalents$193,712K Receivable fromcollaboration partner$53,663K Prepaid expenses andother current assets$12,006K Total current assets$613,455K Marketable securities -noncurrent$72,548K Operating leaseright-of-use asset$7,390K Property and equipment,net$3,778K Restricted cash -noncurrent$288K Total assets$697,459K Total liabilities andstockholders' equity$697,459K Total stockholders'equity$655,473K Total liabilities$41,986K Accumulated deficit-$466,888K Accumulated othercomprehensive (loss) income-$269K Additional paid-in capital$1,122,629K Total currentliabilities$34,549K Operating lease liability- noncurrent$7,437K Common stock, 0.00001par value,...$1K Accrued expenses andother payables$17,491K Accounts payable$8,437K Deferred revenue$6,282K Operating lease liability$2,339K

Protagonist Therapeutics, Inc (PTGX)

Protagonist Therapeutics, Inc (PTGX)